Forte Biosciences, Inc. (FBRX)
2025-06-30 | ||||
---|---|---|---|---|
Other income, net | 330 | |||
Research and development | 8,469 | |||
General and administrative | 2,960 | |||
Research and development - related party | 150 | |||
Total operating expenses | 11,579 | |||
Loss from operations | -11,579 | |||
Net loss | -11,249 | |||
Net loss per share - basic | -0.96 | |||
Net loss per share - diluted | -0.96 |